News Conference News ESC 2022 CV Care Around Noncardiac Surgery: New ESC Guidelines Michael O'Riordan September 07, 2022
News Daily News NIH Presses Pause on Cardiac Stem Cell Trial, Further Muddying a Murky Field Shelley Wood November 02, 2018
News Industry News BioCardia Receives New Potency Assay Patent, Providing Further Protection to Autologous Cell Therapy Programs in Heart Failure and Refractory Angina April 25, 2018
Presentation TCT 2017 First Experience With the Coronary Sinus Reducer System for the Management of Refractory Angina in Patients Without Obstructive Coronary Artery Disease Presenter: Daniel Burkhoff, Samir R. Kapadia, Alaide Chieffo November 01, 2017
Presentation TCT 2013 The Coronary Sinus Reducer – a Device Based Therapy for Refractory Angina; Interim Safety Results of the ongoing COSIRA clinical Trial and efficacy results of the CS Reducer... Presenter: Shmuel Banai, Marc Jolicoeur, Jean-Fran?ois Tanguay, Elazer Edelman, Stefan Verheye January 31, 2013